Product Information
PHENOBARBITAL 32.4 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0786 per EA under NDC 00904657561. Its NADAC has been published 505 times since Feb 1, 2017.
Strength
32.4 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904657561
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
2/1/2003
Price Statistics
The NADAC for PHENOBARBITAL 32.4 MG TABLET has been published 505 times since Feb 1, 2017, and over the history we have for it it has declined 84.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0786 per EA |
|---|---|
| All-time high | $0.5079 (Feb 15, 2017) |
| All-time low | $0.0732 (Jul 22, 2026) |
| 52-week high | $0.1474 |
| 52-week low | $0.0732 |
| Median price | $0.2828 |
| Average price | $0.2812 |
| Largest weekly change | +62.6% (Jun 19, 2024) |
| Weeks tracked | 505 |
| Tracking since | Feb 1, 2017 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
phenobarbital market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 32.4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 32.4 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0786 per EA (NDC 00904657561), effective Sep 30, 2026.
How has the price of PHENOBARBITAL 32.4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 32.4 MG TABLET has declined 84.5%. It has been tracked across 505 weekly CMS publications since Feb 1, 2017.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 32.4 MG TABLET?
Since Feb 1, 2017, the NADAC for PHENOBARBITAL 32.4 MG TABLET has ranged from a low of $0.0732 (Jul 22, 2026) to a high of $0.5079 (Feb 15, 2017), with a median of $0.2828 per EA.
Are there cheaper alternatives to PHENOBARBITAL 32.4 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PHENOBARBITAL 32.4 MG TABLET, is $0.0732 per EA — about 7% below PHENOBARBITAL 32.4 MG TABLET.
Who manufactures PHENOBARBITAL 32.4 MG TABLET?
PHENOBARBITAL 32.4 MG TABLET (NDC 00904657561) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.